Table 2. Clinical measures before and after 8 weeks of risperidone treatment (N = 80).

	Before treatment	After treatment	t value	p value
Weight (Kg)	62.05±10.53	64.06±10.17	−8.90	<0.001
BMI (kg/m2)	22.24±1.86	22.99±1.8	−9.08	<0.001
blood glucose (mmol/l)	4.74±0.45	4.76±0.43	−1.44	0.124
triglyceride (mmol/l)	0.79±0.20	0.81±0.16	−3.11	0.001
cholesterol (mmol/l)	4.45±0.48	4.48±0.43	−3.49	0.001
LDL (mmol/l)	2.07±0.50	2.11±0.47	−1.33	0.189
HDL (mmol/l)	1.27±.015	1.26±0.15	2.05	0.043
PANSS total	71.83±7.18	53.09±8.00	28.47	<0.001
PANSS positive	20.78±4.97	13.71±2.89	13.30	<0.001
PANSS negative	15.00±4.43	10.64±2.12	9.88	<0.001
PANSS general	36.05±8.15	28.90±8.21	10.14	<0.001

BMI: body mass index; PANSS: Positive and Negative SyndromeScale.